These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 31965757)

  • 1. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
    Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy.
    Dubuisson N; Davis-López de Carrizosa MA; Versele R; Selvais CM; Noel L; Van den Bergh PYD; Brichard SM; Abou-Samra M
    Front Immunol; 2022; 13():1049076. PubMed ID: 36569900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.
    Lecompte S; Abou-Samra M; Boursereau R; Noel L; Brichard SM
    Cell Mol Life Sci; 2017 Jul; 74(13):2487-2501. PubMed ID: 28188344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy.
    Abou-Samra M; Boursereau R; Lecompte S; Noel L; Brichard SM
    Am J Pathol; 2017 Jul; 187(7):1577-1585. PubMed ID: 28463682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy.
    Boursereau R; Abou-Samra M; Lecompte S; Noel L; Brichard SM
    BMC Biol; 2018 Mar; 16(1):33. PubMed ID: 29558930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of adiponectin in the pathogenesis of dystrophinopathy.
    Abou-Samra M; Lecompte S; Schakman O; Noel L; Many MC; Gailly P; Brichard SM
    Skelet Muscle; 2015; 5():25. PubMed ID: 26257862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle.
    Dubuisson N; Versele R; Davis-López de Carrizosa MA; Selvais CM; Noel L; Planchon C; Van den Bergh PYK; Brichard SM; Abou-Samra M
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
    Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
    Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy.
    Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Morris B; Alkhomsi IA; Finck BN; Voss AA; Ren H
    J Transl Med; 2024 Jul; 22(1):664. PubMed ID: 39014470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
    González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.
    Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Voss AA; Ren H
    J Physiol; 2023 Mar; 601(5):961-978. PubMed ID: 36715084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.
    Xu D; Zhao L; Jiang J; Li S; Sun Z; Huang X; Li C; Wang T; Sun L; Li X; Jiang Z; Zhang L
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1306-1320. PubMed ID: 32869445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.